Skip to main content
Clinical Trials/DRKS00033148
DRKS00033148
Recruiting
未知

Diagnostic continuous glucose monitoring to improve the care of pediatric patients with hypocortisolism - Cort-CGM

niversitätsklinikum Düsseldorf0 sites20 target enrollmentAugust 13, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitätsklinikum Düsseldorf
Enrollment
20
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 13, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Düsseldorf

Eligibility Criteria

Inclusion Criteria

  • Confirmed diagnosis of central or primary adrenal insufficiency.
  • Hypocortisolism should be treated permanently (for 3 months) with hydrocortisone or another cortisone preparation

Exclusion Criteria

  • Acute derailments during the last 7 days.
  • Patients with congenital adrenal hyperplasia (CAH) will not be able to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials